Collection-image

TOPICAL COLLECTIONS

Methods for Activation and Expansion of T Cells

Submit Abstract

Guest Editor

Kyung-Ho Roh

Kyung-Ho Roh

University of Alabama, Huntsville, AL

Dr. Kyung-Ho Roh is an Assistant Professor in the Department of Chemical and Materials Engineering Department at the University of Alabama in Huntsville. Dr. Roh received his PhD in macromolecular science and engineering from the University of Michigan in 2008, and his MS and BS degrees in fiber and polymer science and engineering from Seoul National University, South Korea. Upon completion of his PhD, he studied for five years at the School of Medicine at Stanford University for his postdoctoral research on T cell immunology. Immediately before joining UAH, Dr. Roh worked as a Research Scientist in the Biomedical Engineering Department at the Georgia Institute of Technology, where he also served as a Program Manager for the National Cell Manufacturing Consortium. His ongoing research interests are at the intersection of biomaterials engineering and immunology, with three overarching themes of developing molecular engineering strategies to fortify or interrupt various receptor-ligand interactions, developing biomaterials-based artificial microenvironments for effective induction of adaptive immunity, and leveraging biomaterials for controlled immuno-activation or modulation in selective immune cell populations. The end goal of his research is the development of biomaterials-enabled translational cellular and molecular immunotherapies.

Collection Overview

In physiology, the activation and clonal expansion of antigen-specific T cells are essential events for the successful generation of adaptive immune responses. T-cell activation is initiated by specific molecular interactions between the T cell receptor (TCR)-CD3 complex on T cells and the antigenic peptide presented by major histocompatibility complex (MHC) molecules on the surface of either antigen presenting cells (APCs) or target cells. Additionally, the presence of costimulatory and immune checkpoint inhibitors on APCs or target cells determines the quality and quantity of T cell activation and the subsequent fate of the T cell clone.

Spanning from routine laboratory studies on T cell biology to manufacturing processes involved in T cell adoptive therapies (e.g. tumor-infiltrating lymphocytes (TIL) and chimeric antigen receptor (CAR) T cells), proper activation of the T cells is critically necessary. This Methods Collection aims to bring together the conventional and novel methods of T cell activation, as well as the relevant techniques to characterize the consequences of each activation method. For example, T cell activation and expansion using soluble reagents, commercially available products, natural and artificial APCs, bioreactors, and novel scaffold platforms are highly anticipated. Various characterization techniques such as flow cytometry, microscopy, and cell counting methods should be supplemented to examine and monitor the quantity and quality of each T cell activation method. 

Articles

Production of Human CRISPR-Engineered CAR-T Cells
6:33

Production of Human CRISPR-Engineered CAR-T Cells

0 Views

•

Cited by 19

•

2021

•

Abstracts

Enriching the antigen-specificity of virus-specific T-cells

Cliona Rooney*1

1Texas Children's Hospital